CGON Earnings Cg Oncology, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–13 of 13
| Q1 2026 | 2026-03-31 | -0.71 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | -2.08 | 2026-02-27 | 10-K |
| Q3 2025 | 2025-09-30 | -1.57 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.00 | 2025-08-08 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.45 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | -1.41 | 2026-02-27 | 10-K |
| Q3 2025 | 2024-09-30 | -0.93 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.63 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.36 | 2025-05-13 | 10-Q |
| FY 2025 | 2023-12-31 | -15.65 | 2026-02-27 | 10-K |
| Q3 2024 | 2023-09-30 | -11.18 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -7.15 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -3.22 | 2024-05-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.